Cysteine and Ezetimibe drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cysteine (n - acetyl cysteine) and Ezetimibe (ezetimibe). Common drug interactions include body tinea among females and erythema multiforme among males.

The phase IV clinical study analyzes what interactions people have when they take Cysteine and Ezetimibe. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Cysteine?

Cysteine has active ingredients of n - acetyl cysteine. eHealthMe is studying from 1,755 Cysteine users. Check the latest studies of Cysteine.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

On Jul, 19, 2026

11 people who take Cysteine and Ezetimibe together, and have interactions are studied.

Cysteine and Ezetimibe drug interactions.

What are the common drug interactions of Cysteine and Ezetimibe, by gender? *:

female:

Body tinea (ringworm of the body)
Bone density decreased
Cataract (clouding of the lens inside the eye)
Cellulitis (infection under the skin)
Contusion (a type of hematoma of tissue in which capillaries)
Drug ineffective
Fatigue (feeling of tiredness)
Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
Herpes zoster
Hyperlipidaemia (presence of excess lipids in the blood)

male:

Erythema multiforme (a type of hypersensitivity reaction)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Drug eruption (adverse drug reaction of the skin)
Erythema (redness of the skin)
Malaise (a feeling of general discomfort or uneasiness)
Pain
Pruritus (severe itching of the skin)
Pyrexia (fever)
Rash
Toxic skin eruption (skin breakdown due to toxic substance)

What are the common drug interactions of Cysteine and Ezetimibe, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Body tinea (ringworm of the body)
Bone density decreased
Cataract (clouding of the lens inside the eye)
Cellulitis (infection under the skin)
Contusion (a type of hematoma of tissue in which capillaries)
Drug ineffective
Fatigue (feeling of tiredness)
Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
Herpes zoster
Hyperlipidaemia (presence of excess lipids in the blood)

60+:

Erythema multiforme (a type of hypersensitivity reaction)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Drug eruption (adverse drug reaction of the skin)
Erythema (redness of the skin)
Malaise (a feeling of general discomfort or uneasiness)
Pain
Pruritus (severe itching of the skin)
Pyrexia (fever)
Rash
Toxic skin eruption (skin breakdown due to toxic substance)

What are the existing conditions these people have? *

Migraine (headache): 5 people, 45.45%
Complex Regional Pain Syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)): 5 people, 45.45%
Insomnia (sleeplessness): 4 people, 36.36%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 36.36%
High Blood Pressure: 2 people, 18.18%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 1 person, 9.09%
Hepatic Steatosis (fatty liver disease): 1 person, 9.09%
Dyslipidaemia (abnormal amount of lipids): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cysteine and Ezetimibe?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously